Studies of immunity and bacterial invasiveness in mice given a recombinant Salmonella vector encoding murine interleukin-6

Infection and Immunity

Volumn 64, Issue 7, 1996, Pages 2730-2736

  Dunstan, Sarah J ^a   Ramsay, Alistair J ^b   Strugnell, Richard A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; HOST RESISTANCE; IMMUNOTHERAPY; LAMINA PROPRIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLOSIS; SPLEEN CELL;

EID: 0029967261     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.7.2730-2736.1996     Document Type: Article

References (35)

1. Aarden, L. A., E. R. De Groot, O. L. Schaap, and P. M. Lansdorp. 1987. Production of hybridoma growth factor by human monocytes. Eur. J. Im- munol. 17:1411-1416.
2. 1a.Allen, J. S. Unpublished data.
3. Amann, E., and J. Brosius. 1985. 'ATG vectors" for regulated high-level expression of cloned genes in Escherichia coli. Gene 40:183-190.
4. Beagley, K. W., S. Bao, A. J. Ramsay, J. H. Eldridge, and A. J. Husband. 1995. IgA production by peritoneal cavity B cells is IL-6 independent: implications for intestinal IgA responses. Eur. J. Immunol. 25:2123-2126.
5. Beagley, K. W., J. H. Eldridge, F. Lee, H. Kiyono, M. P. Everson, W. J. Koopman, T. Hirano, T. Kishimoto, and J. R. McGhee. 1989. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J. Exp. Med. 169:2133-2148.
6. + for all three chromosomally located systems of DNA restriction and modification. J. Bacteriol. 156:471-474.
7. Carrier, M. J., S. N. Chatfield, G. Dougan, U. T. A. Nowicka, D. O'Callaghan, J. E. Beesley, S. Milano, E. Cillari, and F. Y. Liew. 1992. Expression of human IL-1β in Salmonella typhimurium. A model system for the delivery of recombinant therapeutic proteins in vivo. J. Immunol. 148: 1176-1181.
8. Chiu, C.-P., C. Moulds, R. L. Coffman, D. Rennick, and F. Lee. 1988. Multiple biological activities are expressed by a mouse interleukin-6 cDNA clone isolated from bone marrow stromal cells. Proc. Natl. Acad. Sci. USA 85:7099-7103.
9. Cohen, J. 1993. AIDS research: the mood is uncertain. Science 260:1254-1255.
10. Curtiss, R., R. Goldschmitt, R. Pastian, M. Lyons, S. M. Michalek, and J. Mestecky. 1986. Cloning virulence determinants from Streptococcus mutans and the use of recombinant clones to construct bivalent oral vaccine strains to confer protective immunity against S. mutans-induced dental caries, p. 173-180. In S. Hamada, S. M. Michalek, H. Kiyono, L. Menaker. and J. K. McGhec (ed.), Molecular microbiology and immunology of Streptococcus mutant. Elsevier, Amsterdam.
11. Denich, K., P. Borlin, P. D. O'Hanley, M. Howard, and A. W. Heath. 1993. Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing. Infect. Immun. 61:4818-4827.
12. Dunkler, M. L., and A. J. Husband. 1989. Role of antigen in migration patterns of T cell subsets arising from gut-associated lymphoid tissue. Reg. Immunol. 2:213-224.
13. Fairweather, N. F., S. N. Chatfield, A. J. Makoff, R. A. Strugnell, J. Bester, D. J. Maskell, and G. Dougan. 1990. Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect. Immun. 58:1323-1326.
14. Fletcher Starnes, H., M. K. Pearce, A. Tewari, J. H. Yim, J. Zou, and J. S. Abrams. 1990. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-α challenge in mice. J. Immunol. 145:4185-4191.
15. Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature (London) 291:238-239.
16. Jones, P. W., G. Dougan, C. Hayward, N. Mackensie, P. Collins, and S. N. Chatfield. 1991. Oral vaccination of calves against experimental Salmonellosis using a double aro mutant of Salmonella typhimurium. Vaccine 9:29-34.
17. Kaufmann, S. H. E., and C. H. Ladel. 1994. Application of knockout mice to the experimental analysis of infections with bacteria and protozoa. Trends Microbiol. 7:235-242.
18. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Koehler. 1994. Impaired immune and acute phase responses in IL-6-deficient mice. Nature (London) 368:339-342.
19. Kung, V. T., and G. M. K. Humphries. 1987. Kinetic ELISA in microtitre plates. Clin. Chem. 33:1573-1574.
20. Maskell, D. J., K. J. Sweeney, D. O'Callaghan, C. E. Hormaeche, F. Y. Liew, and G. Dougan. 1987. Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems. Microb. Pathog. 2:211-221.
21. McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. H. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75-88.
22. Ndububa, D. A., G. E. Erhabor, and D. O. Akinola. 1992. Typhoid and paratyphoid fever: a retrospective study. Trop. Gastroenterol. 13:50-63.
23. O'Callaghan, D., D. Maskell, J. Tite, and G. Dougan. 1990. Immune responses in BALB/c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains. Immunology 69:184-189.
24. Okada, M., N. Sakaguchi, N. Yoshimura, H. Hara, K. Shimizu, N. Yoshida, K. Yoshizaki, S. Kishimoto, Y. Yamamura, and T. Kishimoto. 1983. B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J. Exp. Med 157:583-590.
25. Ramsay, A. J., A. J. Husband, I. A. Ramshaw, S. Bao, K. I. Matthaei, G. Koehler, and M. Kopf. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264:561-563.
26. Ramsay, A. J., and M. Kohonen-Corish. 1993. Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo. Bur. J. Immunol. 23:3141-3145.
27. Ramsay, A. J., I. A. Ramshaw, and M. Kopf. 1994. Enhancement of specific mucosal IgA responses by interleukins 5 and 6 encoded in recombinant vaccine vectors, p. 35-39. In F. Brown, R. Chanock, H. Ginsberg, and E. Norrby (ed.), Vaccines 94. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
28. Rubins-Browne, R. M., and V. Bennett-Wood. 1992. Quantitative assessment of the ability of Escherichia coli to invade cultured animal cells. Microb. Pathog. 12:159-164.
29. Schödel, F., S. M. Kelly, D. L. Peterson, D. R. Milich, and R. Curtiss III. 1994. Hybrid hepatitis B virus core pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination. Infect. Immun. 62:1669-1676.
30. Schödel, F., and H. Will. 1990. Expression of hepatitis B virus antigens in attenuated salmonellae for oral immunization. Res. Microbiol. 141:831-837.
31. Sedgwick, J. D., and P. G. Holt. 1983. A solid phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 57:301-309.
32. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
33. Tsang, V. C., R. C. Wilson, and J. M. Peralta. 1983. Quantitative single tube kinetic dependent K-ELISA assay. Methods Enzymol. 92:391-403.
34. Turner, S. J., V. R. Carbone, and R. A. Strugnell. 1993. Salmonella typhimurium ΔaroA ΔaroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T cells in mice. Infect. Immun. 61:5374-5380.
35. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides extraction with phenol-water and further applications of the procedure. Methods Carbohydr. Chem. 5:83-91.